For the Culture By The Culture. ISSN: 3064-9331.
New York legalized cannabis and opened hundreds of stores, but regulators now warn the legal market may not produce enough weed to keep them stocked. With nearly 600 stores open and sales nearing $3 billion, the state is discovering that legalization alone does not guarantee a functioning market.
Louisiana HB 373 would create a tightly controlled adult-use cannabis pilot overseen by the Louisiana Department of Health. The bill limits participation to existing medical marijuana dispensaries, imposes permit renewal fees and a 3.5 percent wholesale assessment, and sunsets July 1, 2030, forcing lawmakers to decide whether to make legalization permanent.
A proposed federal hemp framework is being sold as long overdue clarity for a chaotic market. But beneath the promise of order, the structure reveals rigid caps, unresolved enforcement questions, and a quiet shift of power away from states and smaller producers. We break down what the proposal does, what it avoids, and why the difference matters.
Federal officials claim cannabis is moving forward, but Schedule III changes nothing that matters. This investigation breaks down what rescheduling actually does, what it deliberately avoids, and why prohibition logic remains intact. Arrests continue. Markets remain conflicted. Reform language replaces reform action. The system shifts labels while preserving control.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
Cannabis rescheduling keeps resurfacing in headlines, then vanishes without action. This feature breaks down how federal officials repeatedly float reform language, let deadlines pass, and leave the law untouched. By tracing the mechanics behind the stall, the piece exposes why delay is intentional, who benefits from it, and why cannabis reform remains trapped in federal limbo.
